tirzepatide a Compound Tirzepatide / Niacinamide Injection |
Description
This is normal physiology, not a sign that semaglutide has stopped working
However, significant weight gain, defined as a 7% or more increase in body weight, is uncommon
The primary endpoint was HbA1c change from baseline at week 12
Studies have shown as the Compounded Tirzepatide dosage gradually increases, patients typically see more significant weight loss around the 12-week mark with rapid weight loss tapering off around the 6-month mark
But unlike semaglutide, tirzepatide also targets fellow hormone GIP, which stimulates the release of insulin
